王程简介

Email: wangc90@cczu.edu.cn

王程，海南澄迈人。浙江大学药剂学博士。以第一作者或者通讯作者在Advanced Materials, Small，Journal of Controlled Release, Theranostics, Advanced Healthcare Materials, Nanoscale, Chemical Communications, Acta Biomaterialia，Carbohydrate Polymers等杂志发表论文。累计已发表SCI收录论文30余篇。受邀成为ACS Nano, Materials Science & Engineering C, Journal of Materials Chemistry B, Molecular Pharmaceutics, Biomedicine & Pharmacotherapy等杂志审稿人。文章被引用1000余次，h-index为21。

研究方向：脂质纳米递药系统的构建及研究

主要工作及教育经历

2008.08-2012.06: 中国药科大学（制药工程，学士）

2012.08-2015.06: 中国药科大学（制药工程，硕士）

2015.08-2019.06: 浙江大学（药剂学，博士）

2020.07-至今: 常州大学药学院制药工程系

代表性成果：

(1)Tao Shan^#, Yu Fangying^#, Song Yanqing, Zhou Wentao, Lv Jianghong, Zhao Rui, Wang Cheng*, Fuqiang Hu, Yuan Hong*. Water/pH dual responsive in situ calcium supplement collaborates simvastatin for osteoblast promotion mediated osteoporosis therapy via oral medication. Journal of Controlled Release. 2021;329:121-135.

(2) Wang Cheng, Chen Shaoqing, Yu Fangying, Lv Jianghong, Zhao Rui, Hu Fuqiang, Yuan Hong*. Dual-Channel Theranostic System for Quantitative Self-Indication and Low-Temperature Synergistic Therapy of Cancer. Small. 2021;17(10):2007953.

(3) Wang Jianwei^#, Tao Shan^#, Jin Xiangyu, Song Yanqing, Zhou Wentao, Lou Haiya, Zhao Rui, Wang Cheng*, Hu Fuqiang, Yuan Hong*. Calcium supplement by tetracycline guided amorphous calcium carbonate potentiates osteoblast promotion for synergetic osteoporosis therapy. Theranostics. 2020;10(19):8591.

(4) Wang Cheng, Chen Shaoqing, Bao Lu, Liu Xuerong, Hu Fuqiang, Yuan Hong*. Size-controlled preparation and behavior study of phospholipid–calcium carbonate hybrid nanoparticles. International Journal of Nanomedicine. 2020;15:4049-4062.

(5) Wang Cheng^#, Han Min^#, Liu Xuerong, Chen Shaoqing, Hu Fuqiang, Sun Jihong*, Yuan Hong*. Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy. International Journal of Nanomedicine. 2019;14:1503.

(6) Wang Cheng, Yu Fangying, Liu Xuerong, Chen Shaoqing, Wu Rui, Zhao Rui, Hu Fuqiang, Yuan Hong*. Cancer-Specific Therapy by Artificial Modulation of Intracellular Calcium Concentration. Advanced Healthcare Materials. 2019;8(18):1900501.

(7) Wang Cheng, Liu Xuerong, Chen Shaoqing, Hu Fuqiang, Sun Jihong*, Yuan Hong*. Facile preparation of phospholipid–amorphous calcium carbonate hybrid nanoparticles: toward controllable burst drug release and enhanced tumor penetration. Chemical Communications. 2018;54(93):13080-13083.

(8) Wang Cheng, Chen Shaoqing, Wang Yunxin, Liu Xuerong, Hu Fuqiang, Sun Jihong*, Yuan Hong*. Lipase-triggered water-responsive “Pandora's Box” for cancer therapy: Toward induced neighboring effect and enhanced drug penetration. Advanced Materials. 2018;30(14):1706407.

(9) Wang Cheng, Chen Shaoqing, Yu Qin, Hu Fuqiang, Yuan Hong*. Taking advantage of the disadvantage: employing the high aqueous instability of amorphous calcium carbonate to realize burst drug release within cancer cells. Journal of Materials Chemistry B. 2017;5(11):2068-2073.